Lipid combination
By combining mussel lipids and krill oil, the synergistic inhibition of inflammatory mediators solves the side effects problem of existing anti-inflammatory drugs, providing a safer and more effective solution for treating chronic inflammation and pain.
Patent Information
- Application Number
- CN202511452174.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2017-12-22
- Filing Date
- 2018-12-21
- Publication Date
- 2026-01-13
AI Technical Summary
Existing anti-inflammatory drugs such as NSAIDs and glucocorticoids have side effects when treating inflammation and pain, and NSAIDs may cause gastrointestinal, renal and cardiovascular toxicity with long-term use, posing safety concerns.
This product provides a combination of mussel lipids and krill oil, which, when applied alone or simultaneously, synergistically inhibit one or more pro-inflammatory mediators in the inflammatory process, including nitric oxide (NO), cytokines such as interleukin (IL-6), prostaglandins (PGE2), and TNFα, thereby reducing inflammation and pain.
This combination reduces the side effects of NSAIDs in treating inflammation and pain, providing a safer anti-inflammatory effect, and is suitable for chronic inflammation and related symptoms such as pain, fever, redness and swelling, especially disorders such as osteoarthritis and rheumatoid arthritis.